# MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor

> **NCT05424445** · PHASE3 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 884 (actual)

## Conditions studied

- Induced Vaginal Delivery

## Interventions

- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT05424445
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-21
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-05-21
- **Target enrollment:** 884 (ACTUAL)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05424445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05424445, "MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05424445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*